Muthusamy Shanmugam
Chief Tech/Sci/R&D Officer bei ANI PHARMACEUTICALS, INC.
Vermögen: 59 Mio $ am 31.03.2024
Profil
Mr. Muthusamy Shanmugam is a Director & Head-Research & Development at ANI Pharmaceuticals, Inc. and a Chief Operating Officer, Director & Head-R&D at Novitium Pharma LLC.
He is on the Board of Directors at ANI Pharmaceuticals, Inc., Nuray Chemicals Pvt Ltd., Novitium Pharma LLC and Saimirra Innopharm Pvt Ltd.
He received his graduate degree from The Tamil Nadu Dr. M.G.R.
Medical University and a graduate degree from JSS College of Pharmacy.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
19.04.2024 | 856 272 ( 4,06% ) | 59 Mio $ | 31.03.2024 |
Aktive Positionen von Muthusamy Shanmugam
Unternehmen | Position | Beginn |
---|---|---|
ANI PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 19.11.2021 |
Nuray Chemicals Pvt Ltd.
Nuray Chemicals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Nuray Chemicals Pvt Ltd. provides pharmaceutical products. It offers nisoldipine, rasagiline mesylate, pioglitazone hydrochloride, rosiglitazone maleate, levofloxacin, paliperidone, atorvastatin calcium, ranolazine, sildenafil, pramipexole, and other related products. The company was founded on June 14, 2012 and is headquartered in Thiruvallur, India. | Director/Board Member | 20.07.2016 |
Novitium Pharma LLC
Novitium Pharma LLC Pharmaceuticals: OtherHealth Technology Part of ANI Pharmaceuticals, Inc., Novitium Pharma LLC is a pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The private company was founded in 2016 by Muthusamy Shanmugam, Chad Gassert, and Vijay Thorappadi and is based in East Windsor, NJ, with operations also in Chennai. Novitium has a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities. Novitium Pharma was acquired by ANI Pharmaceuticals, Inc. on November 22, 2021 for $243.40 million. | Founder | 01.01.2016 |
Saimirra Innopharm Pvt Ltd.
Saimirra Innopharm Pvt Ltd. Pharmaceuticals: MajorHealth Technology Saimirra Innopharm Pvt Ltd is an Indian pharmaceutical company that produces and exports pharmaceutical products. The private company is based in Chennai, India. The company was founded in 2000 by Jaganathan Jayaseelan. | Director/Board Member | 22.10.2012 |
Ausbildung von Muthusamy Shanmugam
The Tamil Nadu Dr. M.G.R. Medical University | Graduate Degree |
JSS College of Pharmacy | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ANI PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Nuray Chemicals Pvt Ltd.
Nuray Chemicals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Nuray Chemicals Pvt Ltd. provides pharmaceutical products. It offers nisoldipine, rasagiline mesylate, pioglitazone hydrochloride, rosiglitazone maleate, levofloxacin, paliperidone, atorvastatin calcium, ranolazine, sildenafil, pramipexole, and other related products. The company was founded on June 14, 2012 and is headquartered in Thiruvallur, India. | Health Technology |
Novitium Pharma LLC
Novitium Pharma LLC Pharmaceuticals: OtherHealth Technology Part of ANI Pharmaceuticals, Inc., Novitium Pharma LLC is a pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The private company was founded in 2016 by Muthusamy Shanmugam, Chad Gassert, and Vijay Thorappadi and is based in East Windsor, NJ, with operations also in Chennai. Novitium has a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities. Novitium Pharma was acquired by ANI Pharmaceuticals, Inc. on November 22, 2021 for $243.40 million. | Health Technology |
Saimirra Innopharm Pvt Ltd.
Saimirra Innopharm Pvt Ltd. Pharmaceuticals: MajorHealth Technology Saimirra Innopharm Pvt Ltd is an Indian pharmaceutical company that produces and exports pharmaceutical products. The private company is based in Chennai, India. The company was founded in 2000 by Jaganathan Jayaseelan. | Health Technology |